1. Home
  2. VELO vs SAVA Comparison

VELO vs SAVA Comparison

Compare VELO & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Velo3D Inc.

VELO

Velo3D Inc.

N/A

Current Price

$18.13

Market Cap

102.9M

Sector

Technology

ML Signal

N/A

Logo Cassava Sciences Inc.

SAVA

Cassava Sciences Inc.

HOLD

Current Price

$2.29

Market Cap

103.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VELO
SAVA
Founded
2014
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.9M
103.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VELO
SAVA
Price
$18.13
$2.29
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$18.00
$5.00
AVG Volume (30 Days)
1.8M
863.6K
Earning Date
02-26-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,158,000.00
N/A
Revenue This Year
$11.94
N/A
Revenue Next Year
$56.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.44
N/A
52 Week Low
$1.43
$1.15
52 Week High
$23.84
$4.98

Technical Indicators

Market Signals
Indicator
VELO
SAVA
Relative Strength Index (RSI) N/A 48.84
Support Level N/A $1.97
Resistance Level N/A $2.19
Average True Range (ATR) 0.00 0.11
MACD 0.00 0.05
Stochastic Oscillator 0.00 85.14

Price Performance

Historical Comparison
VELO
SAVA

About VELO Velo3D Inc.

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Share on Social Networks: